HK1141465A1 - Kits, formulations and solutions having enzymatically-permissive amounts of visualization agents and uses thereof - Google Patents
Kits, formulations and solutions having enzymatically-permissive amounts of visualization agents and uses thereofInfo
- Publication number
- HK1141465A1 HK1141465A1 HK10107930.6A HK10107930A HK1141465A1 HK 1141465 A1 HK1141465 A1 HK 1141465A1 HK 10107930 A HK10107930 A HK 10107930A HK 1141465 A1 HK1141465 A1 HK 1141465A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- permissive
- enzymatically
- kits
- formulations
- amounts
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000012800 visualization Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/046—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Polymers & Plastics (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92953407P | 2007-07-02 | 2007-07-02 | |
EP07111565A EP2011524A1 (en) | 2007-07-02 | 2007-07-02 | Fibrin glue with a visualization agent |
US7103108P | 2008-04-09 | 2008-04-09 | |
PCT/IB2008/052636 WO2009004573A1 (en) | 2007-07-02 | 2008-07-01 | Kits, formulations and solutions having enzymatically-permissive amounts of visualization agents and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1141465A1 true HK1141465A1 (en) | 2010-11-12 |
Family
ID=38654579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10107930.6A HK1141465A1 (en) | 2007-07-02 | 2010-08-19 | Kits, formulations and solutions having enzymatically-permissive amounts of visualization agents and uses thereof |
Country Status (10)
Country | Link |
---|---|
US (2) | US20100203033A1 (en) |
EP (3) | EP2011524A1 (en) |
JP (2) | JP5507453B2 (en) |
CN (2) | CN104707168B (en) |
CA (1) | CA2691972C (en) |
ES (2) | ES2393939T3 (en) |
HK (1) | HK1141465A1 (en) |
IL (1) | IL202939A (en) |
MX (1) | MX2010000343A (en) |
WO (1) | WO2009004573A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2011524A1 (en) * | 2007-07-02 | 2009-01-07 | Omrix Biopharmaceuticals Ltd. | Fibrin glue with a visualization agent |
JP5808898B2 (en) * | 2009-09-29 | 2015-11-10 | 一般財団法人化学及血清療法研究所 | Tissue adhesion inhibitor |
RU2556960C2 (en) * | 2010-01-28 | 2015-07-20 | Омрикс Биофармасьютикалс Лтд. | Method of providing improved sealing by means of fibrin |
CN109789162A (en) * | 2016-09-01 | 2019-05-21 | 普拉斯富瑞有限公司 | Human blood product-derived with reduced fibrinolytic and its purposes in disorder of hemostasis |
CN110290817B (en) | 2017-01-30 | 2020-07-03 | 生命细胞公司 | Transglutaminase-treated products |
WO2020121290A1 (en) * | 2018-12-12 | 2020-06-18 | Omrix Biopharmaceuticals Ltd. | High concentrated protein compositions for preventing tissue adhesion |
IL263679A (en) * | 2018-12-12 | 2019-03-31 | Omrix Biopharmaceuticals Ltd | Kits, methods, and compositions for preventing tissue adhesion |
US11654057B2 (en) | 2020-04-09 | 2023-05-23 | Bio 54, Llc | Devices for bleeding reduction and methods of making and using the same |
WO2023119277A1 (en) * | 2021-12-21 | 2023-06-29 | Omrix Biopharmaceuticals Ltd. | Highly soluble fibrinogen compositions |
US11642324B1 (en) | 2022-03-01 | 2023-05-09 | Bio 54, Llc | Topical tranexamic acid compositions and methods of use thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU646406B2 (en) * | 1989-09-12 | 1994-02-24 | Trustees Of Columbia University In The City Of New York, The | Laser tissue welding with dye enhanced solders |
US5292362A (en) * | 1990-07-27 | 1994-03-08 | The Trustees Of Columbia University In The City Of New York | Tissue bonding and sealing composition and method of using the same |
SE9101853D0 (en) * | 1991-06-17 | 1991-06-17 | Jonas Wadstroem | IMPROVED TISSUE ASHESIVE |
US5792835A (en) | 1991-09-05 | 1998-08-11 | Baxter International Inc. | Method of preparing a topical fibrinogen complex |
EP0534178B1 (en) | 1991-09-27 | 2001-04-18 | Omrix Biopharmaceuticals S.A. | Improved tissue glue prepared by using cryoprecipitate |
WO1993005822A1 (en) | 1991-09-27 | 1993-04-01 | Octapharma Ag | Tissue glue prepared by using cryoprecipitate |
US5702715A (en) * | 1995-10-27 | 1997-12-30 | Drying Technology | Reinforced biological sealants |
US7009034B2 (en) * | 1996-09-23 | 2006-03-07 | Incept, Llc | Biocompatible crosslinked polymers |
AU4648697A (en) * | 1996-09-23 | 1998-04-14 | Chandrashekar Pathak | Methods and devices for preparing protein concentrates |
US6121232A (en) * | 1997-01-31 | 2000-09-19 | Omrix Biopharmaceuticals Sa | Stabilized mixture comprising fibrinogen |
EP0856317A1 (en) | 1997-01-31 | 1998-08-05 | Omrix Biopharmaceuticals S.A. | A stabilized mixture comprising fibrinogen |
US20050049178A1 (en) * | 1999-07-06 | 2005-03-03 | Oberschwabenklinik Gmbh | Agent for the occlusion of blood vessels |
JP2002104996A (en) * | 2000-09-25 | 2002-04-10 | Mochida Pharmaceut Co Ltd | Coloring matter-containing hemostatic composition |
AU2002213195A1 (en) * | 2000-10-13 | 2002-04-22 | Baxter Healthcare S.A. | Reduction or prevention of post-surgical adhesion formation with fibrinogen |
KR100871454B1 (en) | 2001-05-21 | 2008-12-03 | 옴릭스 바이오파머슈티컬즈 에스. 에이. | Removal of plasminogen from protein solutions |
WO2003047530A2 (en) | 2001-12-04 | 2003-06-12 | Woolverton Christopher J | Storage-stable fibrin sealant |
US20070286881A1 (en) * | 2005-07-14 | 2007-12-13 | Brian Burkinshsw | Method, composition and kit for treating degenerated disc disease and discogenic pain |
EP2011524A1 (en) * | 2007-07-02 | 2009-01-07 | Omrix Biopharmaceuticals Ltd. | Fibrin glue with a visualization agent |
-
2007
- 2007-07-02 EP EP07111565A patent/EP2011524A1/en not_active Withdrawn
-
2008
- 2008-07-01 EP EP12172045.2A patent/EP2508211B1/en not_active Not-in-force
- 2008-07-01 MX MX2010000343A patent/MX2010000343A/en active IP Right Grant
- 2008-07-01 CA CA2691972A patent/CA2691972C/en not_active Expired - Fee Related
- 2008-07-01 WO PCT/IB2008/052636 patent/WO2009004573A1/en active Application Filing
- 2008-07-01 EP EP08763426A patent/EP2170414B1/en active Active
- 2008-07-01 JP JP2010514225A patent/JP5507453B2/en active Active
- 2008-07-01 CN CN201510125036.7A patent/CN104707168B/en not_active Expired - Fee Related
- 2008-07-01 ES ES08763426T patent/ES2393939T3/en active Active
- 2008-07-01 CN CN200880105291.3A patent/CN101820927B/en not_active Expired - Fee Related
- 2008-07-01 US US12/665,810 patent/US20100203033A1/en not_active Abandoned
- 2008-07-01 ES ES12172045.2T patent/ES2451025T3/en active Active
-
2009
- 2009-12-24 IL IL202939A patent/IL202939A/en active IP Right Grant
-
2010
- 2010-08-19 HK HK10107930.6A patent/HK1141465A1/en not_active IP Right Cessation
-
2014
- 2014-03-18 JP JP2014054820A patent/JP5937129B2/en not_active Expired - Fee Related
-
2017
- 2017-11-21 US US15/819,773 patent/US20180093010A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL202939A (en) | 2013-02-28 |
US20100203033A1 (en) | 2010-08-12 |
ES2393939T3 (en) | 2013-01-02 |
CA2691972C (en) | 2016-08-16 |
US20180093010A1 (en) | 2018-04-05 |
CA2691972A1 (en) | 2009-01-08 |
EP2170414A1 (en) | 2010-04-07 |
WO2009004573A1 (en) | 2009-01-08 |
EP2508211B1 (en) | 2013-12-18 |
MX2010000343A (en) | 2010-04-30 |
JP5507453B2 (en) | 2014-05-28 |
CN104707168B (en) | 2017-09-01 |
JP2014133747A (en) | 2014-07-24 |
JP5937129B2 (en) | 2016-06-22 |
EP2508211A1 (en) | 2012-10-10 |
CN101820927A (en) | 2010-09-01 |
EP2011524A1 (en) | 2009-01-07 |
EP2170414B1 (en) | 2012-08-29 |
CN104707168A (en) | 2015-06-17 |
CN101820927B (en) | 2015-04-22 |
ES2451025T3 (en) | 2014-03-26 |
JP2010531870A (en) | 2010-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190378T1 (en) | Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same | |
HK1141465A1 (en) | Kits, formulations and solutions having enzymatically-permissive amounts of visualization agents and uses thereof | |
EG25965A (en) | Enzyme and fabric hueing agent containing compositions | |
EP2061476A4 (en) | Compositions containing cdp-choline, and methods of use thereof | |
IL205317A0 (en) | Compositions comprising electrochemically altered aqueous fluids and uses thereof | |
IL193297A0 (en) | Imidazole-based compounds, compositions comprising them and methods of their use | |
IL200889A0 (en) | Compositions and kits for treating influenza | |
EP2153838A4 (en) | Anti-norovirus agent, and composition comprising the same | |
EP2048195A4 (en) | Inorganic-organic hybrid composition and use thereof | |
BRPI0813627A2 (en) | ANTIMICROBIAN PEPTIDIA, COMPOSITIONS AND METHODS OF USE | |
GB0601143D0 (en) | Uses, methods and compositions | |
PL2046289T3 (en) | Compositions and kits of phenylephrine | |
ZA201000992B (en) | Anti-viral compounds, compositions, and methods of use | |
EP2340297A4 (en) | Composition, method of making the same, and use thereof | |
GB0706077D0 (en) | Methods, Compositions and uses thereof | |
IL200387A0 (en) | Heterocylic compounds, compositions comprising them and methods of their use | |
IL207639A0 (en) | Pyrrolopyrimidinecarboxamide compounds, compositions comprising the same and uses thereof | |
GB0819432D0 (en) | Compound, composition and use | |
EP2285953A4 (en) | Rna polyphosphatase compositions, kits, and uses thereof | |
HK1149770A1 (en) | Compositions, methods and kits | |
IL208087A0 (en) | Topical ectoparasiticide compositions and uses thereof | |
EP2247303A4 (en) | Haemostasis- modulating compositions and uses therefor | |
PL2313442T3 (en) | Dispersing agent and its use | |
IL200795A (en) | Prodrug compounds of (+)3-hydroxymorphinan, compositions comprising the same and use thereof | |
AU2009249106A8 (en) | Arylsulfonamide compounds, compositions and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230701 |